Tokyo Electron Limited (TEL) announces the participation in imec’s bio-research program “Human++”.
One of the research tracks within imec’s “Human++” program is the development of next-generation platform technologies, which can be applied to automated cell inspection methods for clinical-grade induced pluripotent stem cells (iPSCs). The agreement between TEL and imec includes the development of compact lens-free imagers to monitor iPSC colonies, and silicon photonics biosensors to quantify biomolecules in culture medium.
To further strengthen their collaboration, TEL will participate in imec’s resident researcher program and send a researcher to imec for joint research in the life science field.
Imec performs world-leading research in nanoelectronics. Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. Imec delivers industry-relevant technology solutions. In a unique high-tech environment, its international top talent is committed to providing the building blocks for a better life in a sustainable society. Imec is headquartered in Leuven, Belgium, and has offices in Belgium, the Netherlands, Taiwan, US, China, India and Japan. Its staff of close to 2,000 people includes more than 600 industrial residents and guest researchers. In 2011, imec's revenue (P&L) was about 300 million euro. Further information on imec can be found at www.imec.be
Imec is a registered trademark for the activities of IMEC International (a legal entity set up under Belgian law as a "stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Government), imec the Netherlands (Stichting IMEC Nederland, part of Holst Centre which is supported by the Dutch Government), imec Taiwan (IMEC Taiwan Co.) and imec China (IMEC Microelectronics (Shangai) Co. Ltd.) and imec India (Imec India Private Limited).